With Covid-related lockdowns, travel restrictions, cancellation and postponement of conferences and events, business development activities have had to change over the last 15 months. Business relationships and partnership activities have to be developed and maintained on line and lead generation has also changed fundamentally.
In this series of conversations, we explore the shift that has taken place in business development, drawing on the experiences of three different Oxfordshire-based companies: The Electrospinning Company, Enara Bio and Saietta. Through these discussions, we explore how each company has changed its approach to business development and consider how Covid has changed the way we work, looking back over the last year, and looking forward beyond 2021.
When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE
Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE
Given the recent wide-ranging consultation on R&D tax relief, it was probably inevitable that reform of the R&D tax relief schemes (now over 20 years old) would be announced in the Chancellor’s Budget on 27 October 2021, although these announcements were headline only with more details to follow. READ MORE